rnrnHong Kong-listed company iFlytek Healthcare (2506.HK) officially announced its entry into the Indonesian market. The company has signed a strategic cooperation memorandum on AI healthcare with PT DSST Mas Gemilang, a local enterprise under Indonesia's Sinar Mas Group, marking the official launch of comprehensive digital healthcare cooperation between the two parties. This project deeply aligns with Indonesia's national public health construction and development plan, and represents an important practice for Chinese smart healthcare enterprises to deepen their presence in the "Belt and Road" digital health sector and expand into emerging markets in Southeast Asia. This strategic cooperation is not a short-term commercial partnership, but a deep-seated deployment built on a foundation of deep mutual trust between government and enterprises. Previously, Indonesia's Deputy Minister of Health personally led a delegation to visit iFlytek Healthcare's headquarters for inspection and exchange, where the two sides reached a high level of consensus on core areas such as grassroots intelligent diagnosis and treatment upgrades, intelligent monitoring and early warning of infectious diseases, and digital construction of the public health system, thus clearing policy and communication obstacles and laying a solid foundation for the implementation of this cooperation. rnrnAs a benchmark domestic enterprise that has repeatedly appeared at the World Health Assembly, iFlytek Healthcare possesses a mature and complete AI healthcare technology system and has accumulated extensive experience in implementing national-level smart healthcare projects, with its technical maturity and practical applicability verified through large-scale domestic scenarios. This cooperation will fully leverage the complementary advantages of both parties' resources, relying on the Sinar Mas Group's government and enterprise channels, digital infrastructure, and local compliance operational advantages accumulated over many years in Indonesia, combined with iFlytek Healthcare's core AI technology, to build an Indonesian healthcare digital cooperation system covering all levels and the entire lifecycle. Cooperation scenarios cover core areas such as AI intelligent diagnosis and treatment systems, national-level public health epidemic monitoring and early warning platforms, intelligent medical imaging diagnostics, remote radiology, and digital upgrades of hospitals and grassroots medical institutions. rnrnAt the same time, industrial investment and localized commercial operations will be promoted in parallel, with mature Chinese AI healthcare solutions being fully implemented. In the future, iFlytek Healthcare will continue to export digital healthcare technologies and operational solutions verified through large-scale domestic practice, helping Indonesia address public health shortcomings, improve overall healthcare service capacity, and epidemic response and prevention levels. Furthermore, the company will use Indonesia as a core strategic hub, gradually expand to the entire ASEAN market, and continuously deepen practical digital healthcare cooperation under the "Belt and Road" framework, facilitating the overseas expansion of Chinese smart healthcare technology into Southeast Asia and creating benchmark projects for cross-border digital health cooperation.